JP5856725B2 - うつ病治療用または予防用医薬組成物 - Google Patents

うつ病治療用または予防用医薬組成物 Download PDF

Info

Publication number
JP5856725B2
JP5856725B2 JP2011169082A JP2011169082A JP5856725B2 JP 5856725 B2 JP5856725 B2 JP 5856725B2 JP 2011169082 A JP2011169082 A JP 2011169082A JP 2011169082 A JP2011169082 A JP 2011169082A JP 5856725 B2 JP5856725 B2 JP 5856725B2
Authority
JP
Japan
Prior art keywords
earthworm
depression
pharmaceutical composition
present
dry powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011169082A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013032308A5 (enExample
JP2013032308A (ja
Inventor
和夫 酒井
和夫 酒井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2011169082A priority Critical patent/JP5856725B2/ja
Publication of JP2013032308A publication Critical patent/JP2013032308A/ja
Publication of JP2013032308A5 publication Critical patent/JP2013032308A5/ja
Application granted granted Critical
Publication of JP5856725B2 publication Critical patent/JP5856725B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2011169082A 2011-08-02 2011-08-02 うつ病治療用または予防用医薬組成物 Active JP5856725B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011169082A JP5856725B2 (ja) 2011-08-02 2011-08-02 うつ病治療用または予防用医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011169082A JP5856725B2 (ja) 2011-08-02 2011-08-02 うつ病治療用または予防用医薬組成物

Publications (3)

Publication Number Publication Date
JP2013032308A JP2013032308A (ja) 2013-02-14
JP2013032308A5 JP2013032308A5 (enExample) 2014-09-04
JP5856725B2 true JP5856725B2 (ja) 2016-02-10

Family

ID=47788495

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011169082A Active JP5856725B2 (ja) 2011-08-02 2011-08-02 うつ病治療用または予防用医薬組成物

Country Status (1)

Country Link
JP (1) JP5856725B2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3091974B1 (en) 2014-01-06 2020-04-01 Shield TX (UK) Limited Dosage regimen of ferric trimaltol
EP3097918B1 (en) * 2014-01-20 2019-04-03 Well Stone Co. Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
JP6321521B2 (ja) * 2014-11-04 2018-05-09 Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 タウ蛋白産生促進剤、タウ蛋白の欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物
RU2696782C1 (ru) * 2018-02-27 2019-08-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) Способ купирования резистентных депрессивных синдромов психосоматического круга

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004292402A (ja) * 2003-03-28 2004-10-21 Mihara Lr Kenkyusho:Kk ミミズ乾燥粉末の製造方法
JP2007153802A (ja) * 2005-12-05 2007-06-21 Fujibio Co Ltd 線溶活性を有するミミズ乾燥粉末及びその製造方法
AU2008248382B2 (en) * 2007-05-07 2013-07-18 Chelsea Therapeutics, Inc. Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders

Also Published As

Publication number Publication date
JP2013032308A (ja) 2013-02-14

Similar Documents

Publication Publication Date Title
JP6985449B2 (ja) 結節性硬化症の治療におけるカンナビジオールの使用
Jagadeesan et al. Current trends in etiology, prognosis and therapeutic aspects of Parkinson’s disease: a review
Didari et al. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis
Standards of Practice Committee et al. Best practice guide for the treatment of REM sleep behavior disorder (RBD)
Zheng et al. Stroke recovery and rehabilitation in 2016: a year in review of basic science and clinical science
JP5856725B2 (ja) うつ病治療用または予防用医薬組成物
CN101790377A (zh) 抗癌剂导致的末梢神经障碍的预防或减轻剂
Xiao et al. Current therapeutics for Alzheimer’s disease and clinical trials
Lee et al. Herbal medicine and acupuncture combined treatment attenuates colitis in rats
KR101737775B1 (ko) 통증 조절 및 탈수초 손상의 역전에서의 ｎ―2―하이드록시―에틸―피페라진―ｎ‘―2―에탄 설폰산（ｈｅｐｅｓ）의 역할
CN106470687A (zh) 烟酰胺单核苷酸在制备防治动脉硬化、心脑血管疾病的保健品中的应用及其保健品
Dashputre et al. Overview of Chronic Diseases
CN104095938A (zh) 一种治疗抑郁症的蒙药制剂
Lenka et al. Sleep disturbances in patients with Parkinson’s disease: it’s time to wake up!
Harris Treating irritable bowel syndrome: A fresh and minty approach to an old therapy
Zhao et al. Observation and analysis of clinical efficacy of melatonin on AOPP-induced delirium patients.
TWI404542B (zh) 用於治療抽動症及具有感覺運動門控不良之精神疾病的海州常山屬組合物
JP2008260728A (ja) 線維筋痛症治療薬
Roze et al. Update on sleep disorders in advanced Parkinson’s disease: a narrative review
US20210162047A1 (en) A Drug For Treating Disorders Of An Organ Or Tissue Function And Diseases Accompanied By Such Disorders, And The Method For Obtaining It.
CN104399060A (zh) 金属硫蛋白复合制剂作为制备穴位介入治疗脑中风后遗症药物的应用
Fymat Tourette's syndrome: III. Treatment Portfolio and Prognosis
Malaspina et al. Disorders of the Motor Cells: The Motor Neuron Diseases
Wu et al. Systemic Modulators: Potential Mechanism for the 5-HT System to Mediate Exercise Amelioration in Alzheimer's
Pass et al. P1-392 Safety, tolerability, and caregiver's impressions of combination therapy with galantamine and memantine for the treatment of Alzheimer's disease

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140715

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140715

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150623

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151208

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151213

R150 Certificate of patent or registration of utility model

Ref document number: 5856725

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250